Essex Investment Management CO LLC Tarsus Pharmaceuticals, Inc. Transaction History
Essex Investment Management CO LLC
- $516 Million
- Q4 2024
A detailed history of Essex Investment Management CO LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Essex Investment Management CO LLC holds 79,760 shares of TARS stock, worth $3.89 Million. This represents 0.86% of its overall portfolio holdings.
Number of Shares
79,760
Previous 109,156
26.93%
Holding current value
$3.89 Million
Previous $3.59 Million
23.01%
% of portfolio
0.86%
Previous 0.67%
Shares
2 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
40.5MCall Options Held
72.7KPut Options Held
313K-
Black Rock Inc. New York, NY3.27MShares$159 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.24MShares$158 Million2.92% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.53MShares$123 Million5.35% of portfolio
-
Jennison Associates LLC2.5MShares$122 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$110 Million9.38% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.3B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...